Control Bionics Ltd
ASX:CBL
Control Bionics Ltd
ASX:CBL
Price:
0.043 AUD
Market Closed
Updated:
May 4, 2024
Control Bionics Ltd
Cash from Financing Activities
|
Control Bionics Ltd
Cash from Financing Activities Peer Comparison
Comparables:
NTI
IPD
C
CYC
COH
EMV
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Control Bionics Ltd
ASX:CBL
|
Cash from Financing Activities
AU$706.4k
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Neurotech International Ltd
ASX:NTI
|
Cash from Financing Activities
AU$9.4m
|
CAGR 3-Years
250%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Cash from Financing Activities
AU$28m
|
CAGR 3-Years
3%
|
CAGR 5-Years
192%
|
CAGR 10-Years
N/A
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cash from Financing Activities
-AU$1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
2%
|
|
|
Cochlear Ltd
ASX:COH
|
Cash from Financing Activities
-AU$377.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-21%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cash from Financing Activities
AU$2.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
See Also
What is Control Bionics Ltd's Cash from Financing Activities?
Cash from Financing Activities
706.4k
AUD
706.4k
AUD
Based on the financial report for Jun 30, 2023, Control Bionics Ltd's Cash from Financing Activities amounts to 706.4k AUD.
What is Control Bionics Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-23%
-23%
The average annual Cash from Financing Activities growth rates for Control Bionics Ltd have been -27% over the past three years , -23% over the past five years .
You don't have any saved screeners yet
